Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia
Clinical trial NCT05050890 · UNKNOWN
Trial details
- NCT number
- NCT05050890
- Sponsor
- Instituto Brasileiro de Controle do Cancer
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-05
- Primary completion
- 2021-11-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.